JINYAN ZHANG: Open Payments
NPI 1801521802 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 18 payments from 11 companies in 2025. Trend: 2023 $618 · 2024 $555 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $254 |
| Agios Pharmaceuticals, Inc. | 3 | $73 |
| Exact Sciences Corporation | 2 | $47 |
| Amgen Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: Epclusa, Livdelzi, PYRUKYND, Cologuard Collection Kit, EVENITY, RINVOQ, GARDASIL 9, IQIRVO.
Industry payments across NY — which companies pay providers there.
